Andrew Gallagher is chief operating officer at Phynova, a British life science company that develops and sells medically licensed drugs, functional ingredients and cosmeceuticals derived from active compounds found in plants.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok